Modified serpinA1 as risk marker for Parkinson’s disease dementia: Analysis of baseline data

Early detection of dementia in Parkinson disease is a prerequisite for preventive therapeutic approaches. Modified serpinA1 in cerebrospinal fluid (CSF) was suggested as an early biomarker for differentiation between Parkinson patients with (PDD) or without dementia (PD). Within this study we aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Halbgebauer, Steffen, Nagl, Magdalena, Klafki, Hans, Haußmann, Ute, Steinacker, Petra, Oeckl, Patrick, Kassubek, Jan, Pinkhardt, Elmar, Ludolph, Albert C., Soininen, Hilkka, Herukka, Sanna-Kaisa, Wiltfang, Jens, Otto, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868992/
https://www.ncbi.nlm.nih.gov/pubmed/27184740
http://dx.doi.org/10.1038/srep26145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868992/
https://www.ncbi.nlm.nih.gov/pubmed/27184740
http://dx.doi.org/10.1038/srep26145

Ejemplares similares